Solara Active Pharma Sciences Limited — Important, 24-07-2026: Updates
24-07-2026 | 02:12 pm
24-07-2026 | 02:12 pm
Solara Active Pharma Sciences announced Q1 consolidated profit jumped to 16.31 Cr on 381.60 Cr revenue. While accumulated losses are 286.21 Cr, management is confident in ongoing operations. Key developments include 442.73 Cr raised from rights issue and a planned demerger of CRAMS/Polymers.
No comments yet. Be the first to comment!
All announcements from Solara Active Pharma Sciences Limited
